Login / Signup
Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study.
Thomas Stranzl
Henrik Ipsen
Lars Harder Christensen
Thomas Eiwegger
Niels Johansen
Kaare Lund
Peter Sejer Andersen
Published in:
Allergy (2020)
Keyphrases
</>
phase iii
open label
clinical trial
double blind
phase ii
randomized controlled trial
placebo controlled